Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma

Blood (2015) 125 (20): 3118–3127.

https://doi.org/10.1182/blood-2014-05-578575

Published: 2015

Includes: Supplemental data

Journal Articles

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

Blood (2014) 124 (9): 1473–1480.

https://doi.org/10.1182/blood-2014-04-571091

Published: 2014

Includes: Supplemental data

Journal Articles

Leukocyte cell-derived chemotaxin 2 (LECT2)–associated amyloidosis is a frequent cause of hepatic amyloidosis in the United States

Oana M. Mereuta, Jason D. Theis, Julie A. Vrana, Mark E. Law, Karen L. Grogg, Surendra Dasari, Vishal S. Chandan, Tsung-Teh Wu, Victor H. Jimenez-Zepeda, Rafael Fonseca, Angela Dispenzieri, Paul J. Kurtin, Ahmet Dogan

Blood (2014) 123 (10): 1479–1482.

https://doi.org/10.1182/blood-2013-07-517938

Published: 2014

Includes: Supplemental data

Journal Articles

Expression of Myc, but not pSTAT3, is an adverse prognostic factor for diffuse large B-cell lymphoma treated with epratuzumab/R-CHOP

Mamta Gupta, Matthew J. Maurer, Linda E. Wellik, Mark E. Law, Jing Jing Han, Nazan Ozsan, Ivana N. Micallef, Ahmet Dogan, Thomas E. Witzig

Blood (2012) 120 (22): 4400–4406.

https://doi.org/10.1182/blood-2012-05-428466

Published: 2012

Includes: Supplemental data

Journal Articles

Expression of MYC but Not pSTAT3 Is an Adverse Prognostic Factor for Diffuse Large B Cell Lymphoma (DLBCL) Treated with Epratuzumab/R-CHOP

Mamta Gupta, Ph.D, Matthew J Maurer, MS, Linda Wellik, Mark E Law, Jing Jing Han, Ivana N. Micallef, MD, Ahmet Dogan, MD, PhD, Thomas E. Witzig, MD

Blood (2012) 120 (21): 1575.

https://doi.org/10.1182/blood.V120.21.1575.1575

Published: 2012

Journal Articles

Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas

Blood (2012) 120 (11): 2280–2289.

https://doi.org/10.1182/blood-2012-03-419937

Published: 2012

Includes: Supplemental data

Journal Articles

Dysregulation of GPR34 in Indolent Lymphomas and Its Function As a Novel Regulator of Cell Growth and Gene Expression

Anne J. Novak, Ph.D., Takashi Akasaka, MD, PhD, Michelle K Manske, Esteban Braggio, PhD, Tammy Price-Troska, Steve Ziesmer, Secreto Frank, Ph.D., Rafael Fonseca, MD, Mamta Gupta, PhD, Mark E Law, Thomas E. Witzig, MD, Martin JS Dyer, MA, DPhil, FRCP, FRCPath, Ahmet Dogan, Ellen McPhail, MD, James R Cerhan, MD, PhD, Stephen Ansell

Blood (2011) 118 (21): 1570.

https://doi.org/10.1182/blood.V118.21.1570.1570

Published: 2011

Journal Articles

Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing

Andrew L. Feldman, Ahmet Dogan, David I. Smith, Mark E. Law, Stephen M. Ansell, Sarah H. Johnson, Julie C. Porcher, Nazan Özsan, Eric D. Wieben, Bruce W. Eckloff, George Vasmatzis

Blood (2011) 117 (3): 915–919.

https://doi.org/10.1182/blood-2010-08-303305

Published: 2011

Includes: Supplemental data

Journal Articles

Massively Parallel Mate Pair DNA Library Sequencing for Translocation Discovery: Recurrent t(6;7)(p25.3;q32.3) Translocations In ALK-Negative Anaplastic Large Cell Lymphomas

Andrew L Feldman, MD, Ahmet Dogan, MD, PhD, MRCPath, David I Smith, PhD, Mark E Law, Stephen M. Ansell, MD, PhD, Sarah H Johnson, Julie C Porcher, Nazan Özsan, MD, Eric D Wieben, PhD, Bruce W Eckloff, George Vasmatzis, PhD

Blood (2010) 116 (21): 633.

https://doi.org/10.1182/blood.V116.21.633.633

Published: 2010

Journal Articles

A Newly Identified Translocation t(X;14)(p11;q32) In MALT Lymphoma Involving IGHS and GPR34 Reveals A Novel Role for GPR34 In Cell Growth and Tumor Development

Stephen M. Ansell, MD, PhD, Takashi Akasaka, MD, PhD, Michelle Manske, Tammy Price-troska, Steven Ziesmer, Esteban Braggio, Rafael Fonseca, Mamta Gupta, Ph.D, Mark E Law, Thomas E. Witzig, MD, Martin JS Dyer, MA, DPhil, FRCP, FRCPath, Ahmet Dogan, M.D., Ph.D., Anne J. Novak, PhD

Blood (2010) 116 (21): 1999.

https://doi.org/10.1182/blood.V116.21.1999.1999

Published: 2010

Journal Articles

Del(6)(q22) and BCL6 Rearrangements in Primary Central Nervous System Lymphoma (PCNSL) Are Indicators of an Aggressive Clinical Course.

Francois M. Cady, MD, Mark E. Law, MS, Caterina Giannini, MD, Alyx B. Porter, MD, Brian P. O’Neill, MD, Paul A. Decker, MD, Paul J. Kurtin, MD, Ellen D. Remstein, MD, Ahmet Dogan, MD

Blood (2007) 110 (11): 1557.

https://doi.org/10.1182/blood.V110.11.1557.1557

Published: 2007

Journal Articles

Syk Tyrosine Kinase Is Overexpressed in the Majority of Peripheral T- and NK-Cell Lymphomas, and Represents a Potential Therapeutic Target.

Andrew L. Feldman, MD, David X. Sun, PhD, Mark E. Law, BS, Anne J. Novak, PhD, Ayoma D. Attygalle, MD, Erik C. Thorland, PhD, Stephanie R. Fink, BA, Julie A. Vrana, PhD, B. Lynn Caron, William G. Morice, MD, PhD, Ellen D. Remstein, MD, Karen L. Grogg, MD, Paul J. Kurtin, MD, William R. Macon, MD, Ahmet Dogan, MD, PhD

Blood (2007) 110 (11): 690.

https://doi.org/10.1182/blood.V110.11.690.690

Published: 2007

NARROW

The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

Leukocyte cell-derived chemotaxin 2 (LECT2)–associated amyloidosis is a frequent cause of hepatic amyloidosis in the United States

Expression of Myc, but not pSTAT3, is an adverse prognostic factor for diffuse large B-cell lymphoma treated with epratuzumab/R-CHOP

Expression of MYC but Not pSTAT3 Is an Adverse Prognostic Factor for Diffuse Large B Cell Lymphoma (DLBCL) Treated with Epratuzumab/R-CHOP

Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas

Dysregulation of GPR34 in Indolent Lymphomas and Its Function As a Novel Regulator of Cell Growth and Gene Expression

Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing

Massively Parallel Mate Pair DNA Library Sequencing for Translocation Discovery: Recurrent t(6;7)(p25.3;q32.3) Translocations In ALK-Negative Anaplastic Large Cell Lymphomas

A Newly Identified Translocation t(X;14)(p11;q32) In MALT Lymphoma Involving IGHS and GPR34 Reveals A Novel Role for GPR34 In Cell Growth and Tumor Development

Del(6)(q22) and BCL6 Rearrangements in Primary Central Nervous System Lymphoma (PCNSL) Are Indicators of an Aggressive Clinical Course.

Syk Tyrosine Kinase Is Overexpressed in the Majority of Peripheral T- and NK-Cell Lymphomas, and Represents a Potential Therapeutic Target.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only